The goal of this program is to improve the management of inflammatory bowel disease (IBD) in the pediatric population using combination therapy, and the transition of care from pediatric to adult gastrointestinal provider for patients with IBD diagnosed in childhood. After hearing and assimilating this program, the clinician will be better able to: 1. Compare the combination of infliximab plus azathioprine with either monotherapy in patients with treatment-naive Crohn disease. 2. Cite literature regarding adult vs pediatric IBD. 3. Explain results of the COMBINE trial comparing anti-tumor necrosis factor (TNF) therapy alone vs anti-TNF therapy plus low-dose methotrexate in pediatric patients with IBD. 4. Implement strategies for assessing a patient s readiness for transition from pediatric to adult IBD care. 5. Identify resources and guidelines available to assist in the transition process of pediatric patients with IBD to adult providers.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 903 Queens Lane
Pricing
CME included with membership · $1,095/yr
| Platinum Membership | $1,095/yr |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiac Anesthesia
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Otology & Neurotology
- Pain Medicine
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Otolaryngology
- Pediatric Radiology
- Pediatric Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Sleep Medicine
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Trauma Surgery
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $1,095 / year
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on audio-digest.orgListed by the provider
- Enduring / On-demand
- Credit · Up to 2 credits
- MOC · Up to 2 points
- Membership pricing
-
ReleasedSep 1, 2026
-
Last day to claim creditJun 19, 2028 2 years left
-
Learner’s Digest International (TM) Combination Therapy for Pediatric Patients with Inflammatory Bowel Disease
-
Learner’s Digest International (TM) Helping Pediatric Patients with IBD Transition to Adult Care
-
Learner’s Digest International (TM) Managing Chronic Pain in Children and Adults with Inflammatory Bowel Disease
-
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Clinical Impacts of Immunomodulator Withdrawal from anti-TNF Combination Therapy in Pediatric Inflammatory Bowel Disease JPGN October 2024
-
Optum Health Education Personalized Medicine in Inflammatory Bowel Disease Management
-
PRIME Education, Inc. (PRIME®) Incorporating the Latest Advances to Optimize Outcomes for Patients With Inflammatory Bowel Disease
